Unknown

Dataset Information

0

Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.


ABSTRACT: BACKGROUND:This study sought to determine whether levothyroxine pharmacokinetics (PKs) are affected by age, weight, and sex. METHODS:A PK study was performed after administration of a tracer dose of carbon-13-labeled LT4 (13C-LT4). The study was conducted at an academic medical center. Adults of any age being treated with levothyroxine for hypothyroidism were enrolled in the study. A single dose of 13C-LT4 was administered. Eighteen serial plasma samples were collected. One sample was obtained before the 13C-LT4 dose, and the majority of the remaining samples were collected over the 120-hour period post dosing. 13C-LT4 concentration was quantified using liquid chromatography tandem mass spectrometry. PK analysis was conducted using a linear log trapezoidal non-compartmental analysis using Phoenix 6.4. RESULTS:Eight males and 33 females with a median age of 50 years (range 22-78 years) and median weight of 65.9 kg (range 50-150 kg) were enrolled in the study. The median 13C-LT4 dose administered was 100 μg (range 70-300 μg). The median oral clearance rate (CL/F), apparent volume of distribution (V/F), time to peak concentration (Tmax), and dose-normalized peak concentration (Cmax) of 13C-LT4 were estimated to be 0.712 L/h, 164.9 L, 4 h, and 7.5 ng/L/μg, respectively. The dose-normalized area under the concentration-time curve from time 0 to 120 hours and half-life of the terminal distribution phase were 0.931 ng.h/mL/μg and 172.2 h, respectively. There was no significant difference in any 13C-LT4 PK parameter between patients aged >60 years (n = 10) and patients aged ≤60 years (n = 31), nor was there a relationship between age as a continuous variable and 13C-LT4 PK parameters. Sex only affected CL/F, V/F, and dose-normalized Cmax in univariate analyses. However, after adjusting for weight, sex was no longer a significant covariate. Weight was a significant predictor for CL/F, V/F and dose-normalized Cmax of 13C-LT4 in multivariate analyses. CONCLUSION:Prior studies suggest that patient age affects levothyroxine dose requirement. This study did not identify an effect of age and suggests that age-related changes in levothyroxine pharmacokinetics may be mediated by age-related weight differences. Physicians should consider a patient's weight, rather than age, for estimating levothyroxine dosage requirement.

SUBMITTER: Younis IR 

PROVIDER: S-EPMC5770123 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Younis Islam R IR   Ahmed Mariam A MA   Burman Kenneth D KD   Soldin Offie P OP   Jonklaas Jacqueline J  

Thyroid : official journal of the American Thyroid Association 20180102 1


<h4>Background</h4>This study sought to determine whether levothyroxine pharmacokinetics (PKs) are affected by age, weight, and sex.<h4>Methods</h4>A PK study was performed after administration of a tracer dose of carbon-13-labeled LT4 (<sup>13</sup>C-LT4). The study was conducted at an academic medical center. Adults of any age being treated with levothyroxine for hypothyroidism were enrolled in the study. A single dose of <sup>13</sup>C-LT4 was administered. Eighteen serial plasma samples were  ...[more]

Similar Datasets

| S-EPMC8767200 | biostudies-literature
| S-EPMC9274147 | biostudies-literature
| S-EPMC3749773 | biostudies-literature
| S-EPMC10858218 | biostudies-literature
| S-EPMC8266819 | biostudies-literature
| S-EPMC8984020 | biostudies-literature
| S-EPMC7171601 | biostudies-literature
| S-EPMC2984178 | biostudies-literature
| S-EPMC3855748 | biostudies-literature
| S-EPMC2903070 | biostudies-literature